Mednet Logo

Would you offer systemic chemotherapy to a patient with at least 2023 FIGO stage IC high grade serous (p53-mut) endometrial cancer with extensive LVI for whom nodal assessment was not done?

Would you offer additional adjuvant treatment (e.g., pelvic EBRT, vaginal brachytherapy, etc.)?
Community PollStarted

What adjuvant therapy(ies) would you recommend to a patient with 2023 IC serous endometrial cancer with extensive LVSI and without nodal assessment?

339 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet MemberInvited Expert
Gynecologic Oncology · University of Alabama at Birmingham
Answered on

This question was addressed in a large NCDB study in 2020 by Nasioudis et al (Nasioudis et al., PMID 32675056) who looked at USC confined to the endometrium, which found that 5-year OS was 91% for chemo alone, 91% for chemoRT, 85% for those who received radiation alone, and 82% who were observed. Ad...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center
Answered on

To recap for those (including myself) who are not routinely using FIGO 2023 staging at the current time - Stage IC uterine cancer is defined as: "Aggressive histological types limited to a polyp or confined to the endometrium."

Given there was no MMI, NCCN does allow for consideration of VCB alone (w...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Allegheny Health Network
Answered on

Was preoperative imaging obtained? Why wasn't nodal assessment done? Could it be done if there are concerning findings on imaging?

If there are suspicious nodes on preoperative imaging (post-operative has to be taken with a grain of salt), I would treat with EBRT following chemotherapy if lymphadene...

Join for free or sign in to see the full answer